Acessibilidade / Reportar erro

Bone single photon emission computed tomography (SPECT) in a patient with Pancoast tumor: a case report

Tomografia óssea computadorizada por emissão de fóton único (SPECT) em paciente com tumor de Pancoast: um relato de caso

Abstracts

CONTEXT: Non-small cell lung carcinomas (NSCLCs) of the superior sulcus are considered to be the most challenging type of malignant thoracic disease. In this disease, neoplasms originating mostly from the extreme apex of the lung expand to the chest wall and thoracic inlet structures. Multiple imaging procedures have been applied to identify tumors and to stage and predict tumor resectability in surgical operations. Clinical examinations to localize pain complaints in shoulders and down the arms, and to screen for Horner's syndrome and abnormalities seen in paraclinical assessments, have been applied extensively for differential diagnosis of superior sulcus tumors. Although several types of imaging have been utilized for diagnosing and staging Pancoast tumors, there have been almost no reports on the efficiency of whole-body bone scans (WBBS) for detecting the level of abnormality in cases of superior sulcus tumors. CASE REPORT: We describe a case of Pancoast tumor in which technetium-99m methylene diphosphonate (Tc-99m MDP) bone single-photon emission-computed tomography (SPECT) was able to accurately detect multiple areas of abnormality in the vertebrae and ribs. In describing this case, we stress the clinical and diagnostic points, in the hope of stimulating a higher degree of suspicion and thereby facilitating appropriate diagnosis and treatment. From the results of this study, further clinical trials to evaluate the potential of SPECT as an efficient imaging tool for the work-up on cases of Pancoast tumor are recommended.

Carcinoma; non-small-cell lung; Pancoast syndrome; Technetium Tc 99m medronate; Tomography; emission-computed; single-photon; Magnetic resonance imaging


CONTEXTO: Carcinomas pulmonares de células não pequenas (NSCLCs) do sulco superior são considerados como o maior desafio nos tumores malignos torácicos. Nesta doença, as neoplasias se originam principalmente do ápice do pulmão e se expandem pela parede e pelas estruturas torácicas. Diversas técnicas de imagem têm sido utilizadas para identificar e estagiar os tumores, permitindo um prognóstico para a sua ressecção em procedimentos cirúrgicos. O exame clínico tem sido bastante usado para diagnóstico diferencial de tumores do sulco superior nas queixas de dores no ombro, síndrome de Horner e anormalidades observadas em exames paraclínicos. Embora diversos tipos de exames de imagem sejam utilizados para diagnóstico e estadiamento de tumores de Pancoast, praticamente não existem relatos sobre a eficácia do exame ósseo do corpo todo (WBBS) na detecção do nível de anormalidade em casos de tumores do sulco superior. RELATO DE CASO: Descrevemos um caso de tumor de Pancoast, em que foi realizada a tomografia computadorizada óssea por emissão de fóton único (SPECT) com metileno difosfonato de tecnécio-99 (Tc-99m MDP). Este exame foi capaz de detectar com acurácia as múltiplas áreas de anormalidade em vértebras e costelas. Ao descrever este caso, os autores ressaltam os pontos clínicos e diagnósticos, esperando estimular maior grau de suspeita, facilitando assim o diagnóstico e tratamento apropriados. A partir dos resultados deste trabalho, outros estudos clínicos podem avaliar o potencial do SPECT como uma ferramenta eficiente de imagem a ser recomendada na investigação de casos de tumor de Pancoast.

Carcinoma pulmonar de células não pequenas; Síndrome de Pancoast; Medronato de tecnécio Tc 99m; Tomografia computadorizada de emissão de fóton único; Imagem por ressonância magnética


CASE REPORT

Bone single photon emission computed tomography (SPECT) in a patient with Pancoast tumor: a case report

Tomografia óssea computadorizada por emissão de fóton único (SPECT) em paciente com tumor de Pancoast: um relato de caso

Hamid JavadiI; Mehdi MogharrabiII; Isa Neshandar AsliIII; Babak ShafieiIV; Mehrzad BahtoeeV; Mohammad SeyedabadiVI; Iraj NabipourVII; Majid AssadiVIII

IMD. Head of Department of Nuclear Medicine, 5th Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran

IIMD. Assistant professor of Nuclear Medicine, Department of Nuclear Medicine, 5th Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran

IIIMD. Head of Department of Nuclear Medicine, Taleghani Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran

IVAssistant professor of Nuclear Medicine , Taleghani Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran

VMD. Assistant professor of Internal Medicine, Tropical and Geographical Research Center , Persian Gulf Biomedical Sciences Institute, Bushehr University of Medical Sciences, Bushehr, Iran

VIPhD. Pharmacologist and researcher in the Bushehr Research Center for Nuclear Medicine, Persian Gulf Biomedical Sciences Institute, Bushehr University of Medical Sciences, Bushehr, Iran

VIIMD. Professor of Internal Medicine, Tropical and Geographical Research Center, Persian Gulf Biomedical Sciences Institute, Bushehr University of Medical Sciences, Bushehr, Iran

VIIIMD. Head of Bushehr Research Center for Nuclear Medicine, Persian Gulf Biomedical Sciences Institute, Bushehr University of Medical Sciences, Bushehr, Iran

Address for correspondence Address for correspondence: Majid Assadi Department of Nuclear Medicine, Persian Gulf Biomedical Sciences Institute, Boostan 19 Alley, Imam Khomeini Street, Bushehr, Iran Tel. 0098-771-2580169 Fax. 0098-771-2541828 E-mail: assadipoya@yahoo.com E-mail: asadi@bpums.ac.ir

ABSTRACT

CONTEXT: Non-small cell lung carcinomas (NSCLCs) of the superior sulcus are considered to be the most challenging type of malignant thoracic disease. In this disease, neoplasms originating mostly from the extreme apex of the lung expand to the chest wall and thoracic inlet structures. Multiple imaging procedures have been applied to identify tumors and to stage and predict tumor resectability in surgical operations. Clinical examinations to localize pain complaints in shoulders and down the arms, and to screen for Horner's syndrome and abnormalities seen in paraclinical assessments, have been applied extensively for differential diagnosis of superior sulcus tumors. Although several types of imaging have been utilized for diagnosing and staging Pancoast tumors, there have been almost no reports on the efficiency of whole-body bone scans (WBBS) for detecting the level of abnormality in cases of superior sulcus tumors.

CASE REPORT: We describe a case of Pancoast tumor in which technetium-99m methylene diphosphonate (Tc-99m MDP) bone single-photon emission-computed tomography (SPECT) was able to accurately detect multiple areas of abnormality in the vertebrae and ribs. In describing this case, we stress the clinical and diagnostic points, in the hope of stimulating a higher degree of suspicion and thereby facilitating appropriate diagnosis and treatment. From the results of this study, further clinical trials to evaluate the potential of SPECT as an efficient imaging tool for the work-up on cases of Pancoast tumor are recommended.

Key words: Carcinoma, non-small-cell lung. Pancoast syndrome. Technetium Tc 99m medronate. Tomography, emission-computed, single-photon. Magnetic resonance imaging.

RESUMO

CONTEXTO: Carcinomas pulmonares de células não pequenas (NSCLCs) do sulco superior são considerados como o maior desafio nos tumores malignos torácicos. Nesta doença, as neoplasias se originam principalmente do ápice do pulmão e se expandem pela parede e pelas estruturas torácicas. Diversas técnicas de imagem têm sido utilizadas para identificar e estagiar os tumores, permitindo um prognóstico para a sua ressecção em procedimentos cirúrgicos. O exame clínico tem sido bastante usado para diagnóstico diferencial de tumores do sulco superior nas queixas de dores no ombro, síndrome de Horner e anormalidades observadas em exames paraclínicos. Embora diversos tipos de exames de imagem sejam utilizados para diagnóstico e estadiamento de tumores de Pancoast, praticamente não existem relatos sobre a eficácia do exame ósseo do corpo todo (WBBS) na detecção do nível de anormalidade em casos de tumores do sulco superior.

RELATO DE CASO: Descrevemos um caso de tumor de Pancoast, em que foi realizada a tomografia computadorizada óssea por emissão de fóton único (SPECT) com metileno difosfonato de tecnécio-99 (Tc-99m MDP). Este exame foi capaz de detectar com acurácia as múltiplas áreas de anormalidade em vértebras e costelas. Ao descrever este caso, os autores ressaltam os pontos clínicos e diagnósticos, esperando estimular maior grau de suspeita, facilitando assim o diagnóstico e tratamento apropriados. A partir dos resultados deste trabalho, outros estudos clínicos podem avaliar o potencial do SPECT como uma ferramenta eficiente de imagem a ser recomendada na investigação de casos de tumor de Pancoast.

Palavras-chave: Carcinoma pulmonar de células não pequenas. Síndrome de Pancoast. Medronato de tecnécio Tc 99m. Tomografia computadorizada de emissão de fóton único. Imagem por ressonância magnética.

INTRODUCTION

Pancoast tumors, first described by Pancoast and Tobias,1-3 account for less than 5% of non-small cell lung carcinomas (NSCLCs).4 They are a rare subgroup of neoplasms that emanate mostly from the apex of the lung and expand to the chest wall and brachial plexus.5 The involvement of subclavian vessels, stellate ganglions, mediastinal lymph nodes and adjacent vertebral bodies demands more sophisticated instruments for surgical treatment and may worsen the survival rate.4 The etiology of the disease includes either primary thoracic carcinomas, or it may be secondary to metastatic or hematological neoplasms and a variety of infections.1

Clinical examinations to localize the cause of pain complaints in shoulders and down the arms, and to screen for Horner's syndrome and abnormalities seen in paraclinical assessments, have been applied extensively for differential diagnosis of superior sulcus tumors. Chest x-ray, computed tomography (CT), whole-body positron emission tomography (PET) and magnetic resonance imaging (MRI) techniques are among the types of imaging examination used for diagnosing and staging Pancoast tumors.6 However, there have been almost no reports on the efficiency of whole-body bone scans (WBBS) for detecting the level of abnormality in cases of superior sulcus tumors. Here, we describe a case of Pancoast tumor that showed multiple areas of abnormalities on WBBS, using planar and single-photon emission-computed tomography (SPECT) views.

CASE REPORT

A 67-year-old male subject with severe hemithorax pain and dyspnea, along with disseminated pain and muscle weakness in the right shoulder and down the arm, was referred to our institution. Pulmonary evaluation revealed coarse as well as dull breathing sounds. Laboratory data showed normocytic normochromic anemia, whereas white blood cells, platelets, liver and renal functions, calcium, phosphorus and alkaline phosphatase (ALP) were all within normal levels and there were no signs of organomegaly or lymphadenopathy. The chest x-ray showed collapse of the right upper lobe. The patient was further evaluated for suspected bronchogenic cancer with brachial plexus involvement. Histopathological analysis showed poorly differentiated squamous cell carcinoma.

CT of the chest, upper abdomen and brain was performed with contrast and revealed some pulmonary nodules with hilar mass, resorptive atelectasis and obstructive pneumonia, along with destruction of the adjacent rib vertebra and extension to the spinal canal; there were no signs of brain involvement (Figure 1). MRI on the chest also demonstrated destruction of vertebrae and invasion into the spinal canal, thereby compressing the spinal cord (Figure 2). MRI on the spine confirmed the presence of a lytic lesion in the T4 vertebral body (Figure 3).




Three hours after administration of 750 MBq (20 mCi) technetium-99m methylene diphosphonate (Tc-99m MDP) by injection, WBBS was performed using a rotating digital gamma camera (ADAC Pegasys) equipped with a low-energy all-purpose parallel whole collimator, with a 20% window centered at 140 keV to provide energy discrimination. SPECT images were obtained in a 128 × 128 matrix, in 64 steps, with 40 s per step. The images were reconstructed and displayed on all three axes: vertical long axis, horizontal long axis and axial short axis. We found an area of diminished radiotracer uptake in the T3-T5 vertebrae and in the posterior arch of the third to fifth right ribs (Figure 4).


The patient was further evaluated for induction chemoradiotherapy and was subsequently subjected to a palliative en-bloc surgical operation with a posterior approach (Figure 5).


DISCUSSION

Assessment of patients with Pancoast tumors is mandatory not only in order to provide a prognosis, but also in order to choose the appropriate treatment approach, so that the morbidity associated with superior sulcus tumors can be minimized.7

CT scans or ultrasound-guided percutaneous transthoracic fine-needle biopsies are considered to be the most sensitive technique for identifying Pancoast tumors, whereas CT scans alone provide information about the extent of the disease and recognition of chest-wall involvement, pulmonary nodules and parenchymal diseases.7,8 Heelan et al. investigated 32 sets of MRI and CT examinations and concluded that MRI is a procedure with greater accuracy in terms of detection of tumor invasion due to Pancoast tumors.9 MRI provides overall better outcomes, not only in determining tumor scope and its extension to the brachial plexus, subclavian vessels, mediastinal lymph node, spinal canal and vertebral bodies, but also in predicting tumor resectability and making radiosensitivity assessments.1,7,10,11

Kubota et al. reported that the C-11 methionine uptake pattern in PET showed that large-cell carcinoma with mediastinal invasion decreased in size following radiotherapy, and this was further confirmed by biopsy. On the other hand, CT showed no noticeable change in tumor dimensions.12

18F-fluoro-2-deoxy-glucose (FDG)-PET has also proven to be notably more precise than CT and provides lower negative predictive values, not only in discriminating between benign and malignant lesions, but also in lymph node staging.13,14 Furthermore, it has been shown that Tc-99m methoxy isobutyl isonitrile (MIBI) SPECT faithfully identifies not only the mediastinal lymph node metastases in patients with NSCLCs,15 but also the chemotherapy response in both small-cell lung carcinoma (SCLC)16 and NSCLCs.17

The functional imaging mode of SPECT has a capability to visualize and measure molecular processes in vivo. However, it suffers from low spatial resolution, in comparison with CT or MRI. One way to improve the diagnostic accuracy of this mode, despite its shortcomings, is to combine the images from this mode with images from CT and MRI.18

By integrating hybrid systems within one gamma camera, the anatomical inaccuracies due to image fusion would be expected to be greatly reduced, compared with software-based image fusion, although inaccuracies in the thorax due to respiratory movements would still exist.19

A dual-headed SPECT camera with a non-diagnostic CT scanner was also recently shown to improve diagnostic specificity with regard to differentiating benign from malignant lesions in bone tissue.20

In searching through the main databases (PubMed, Embase, Lilacs and Cochrane Library), we only found five articles relating to bone scanning on Pancoast tumors (Table 1).21-25 These studies, which described whole-body bone scans performed on these tumors, were taken into consideration in the present study. However, none of them gave any specific emphasis to SPECT.

Recently, some studies have shown that SPECT/spiral-CT considerably improves the diagnostic accuracy of radionuclide bone scanning in staging tumor patients.26,27

Bone scintigraphy is not routinely necessary in investigating Pancoast tumors. Bone pain is the most common reason for performing WBBS,28,29 which may precede the diagnosis of metastasis. WBBS also enables identification of asymptomatic lesions that may produce early local and distant metastatic lesions. As shown in the present case, adding SPECT mode to the planar views in whole-bone scintigraphy can detect local small metastases. We have described this case of Pancoast tumor with emphasis on the clinical and diagnostic points, in the hope of stimulating a higher degree of suspicion and thereby facilitating appropriate diagnosis and treatment.

CONCLUSIONS

Here, we highlighted WBBS using technetium-99m methylene diphosphonate (Tc-99m MDP) in SPECT mode. We indicated that it was able to detect multiple areas of abnormality in the vertebrae and rib region that were shown using CT scans and MRI. However, additionally, WBBS made it possible to identify an asymptomatic lesion in these tumors, which led to changes to the management of this case.

From our observations, we recommend that a well-designed clinical trial to investigate the efficacy of Tc-99m MDP WBBS in SPECT mode should be conducted in order to investigate its potential implementation for Pancoast tumor evaluation.

Date of first submission: September 14, 2009

Last received: June 10, 2010

Accepted: June 18, 2010

Conflict of interest: None

Sources of funding: Not declared

Bushehr Research Center for Nuclear Medicine, Persian Gulf Biomedical Sciences Institute, Bushehr University of Medical Sciences, Bushehr, Iran

  • 1. Arcasoy SM, Jett JR. Superior pulmonary sulcus tumors and Pancoast's syndrome. N Engl J Med. 1997;337(19):1370-6.
  • 2. Pancoast HK. Importance of careful roentgen-ray investigations of apical chest tumors. JAMA. 1924;83:1407-11.
  • 3. Tobias JW. Sindrome apico-costo-vertebral-doloroso por tumor apexiano: su valor diagnostico en el cancer primitivo del pulmon. Rev Med Lat Am. 1932;19:1552-6.
  • 4. Narayan S, Thomas CR. Multimodality therapy for Pancoast tumor. Nat Clin Pract Oncol. 2006;3(9):484-91.
  • 5. Detterbeck FC. Pancoast (superior sulcus) tumors. Ann Thorac Surg. 1997;63(6):1810-8.
  • 6. Jett JR. Superior sulcus tumors and Pancoast's syndrome. Lung Cancer. 2003;42 Suppl 2:S17-21.
  • 7. Rusch VW. Management of Pancoast tumours. Lancet Oncol. 2006;7(12):997-1005.
  • 8. Urschel HC. New approaches to Pancoast and chest wall tumors. Chest. 1993;103(4 Suppl):360S-1.
  • 9. Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology. 1989;170(3 Pt 1):637-41.
  • 10. Beale R, Slater R, Hennington M, Keagy B. Pancoast tumor: use of MRI for tumor staging. South Med J. 1992;85(12):1260-3.
  • 11. Takasugi JE, Rapoport S, Shaw C. Superior sulcus tumors: the role of imaging. J Thorac Imaging. 1989;4(1):41-8.
  • 12. Kubota K, Yamada S, Ishiwata K, Ito M, Ido T. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med. 1992;17(11):877-81.
  • 13. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002;359(9315):1388-93.
  • 14. Vansteenkiste JF. Imaging in lung cancer: positron emission tomography scan. Eur Respir J Suppl. 2002;35:49s-60s.
  • 15. Yamamoto Y, Nishiyama Y, Satoh K, et al. Comparative evaluation of Tc-99m MIBI and Tl-201 chloride SPECT in non-small-cell lung cancer mediastinal lymph node metastases. Clin Nucl Med. 2000;25(1):29-32.
  • 16. Akgun A, Cok G, Karapolat I, Goksel T, Burak Z. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Ann Nucl Med. 2006;20(4):269-75.
  • 17. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Evaluation of radiotherapeutic response in non-small cell lung cancer patients by technetium-99m MIBT and thallium-201 chloride SPET. Eur J Nucl Med. 2000;27(5):536-41.
  • 18. Schulz V, Nickel I, Nömayr A, et al. Effect of CT-based attenuation correction on uptake ratios in skeletal SPECT. Nuklearmedizin. 2007;46(1):36-42.
  • 19. Nakamoto Y, Tatsumi M, Cohade C, et al. Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT. Eur J Nucl Med Mol Imaging. 2003;30(4):597-602.
  • 20. Horger M, Eschmann SM, Pfannenberg C, et al. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR Am J Roentgenol. 2004;183(3):655-61.
  • 21. Haniuda M, Morimoto M, Nishimura H, et al. [A case of chondrosarcoma arising from the left first rib]. Kyobu Geka. 1990;43(10):835-8.
  • 22. Stanford W, Barnes RP, Tucker AR. Influence of staging in superior sulcus (Pancoast) tumors of the lung. Ann Thorac Surg. 1980;29(5):406-9.
  • 23. Fujimura N. [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. III. The ability of detection by bone scintigraphy and roentgenography in bone destructed by Pancoast's tumor (author's transl)]. Nippon Igaku Hoshasen Gakkai Zasshi. 1979;39(9):984-92.
  • 24. Sills M, Pozderac RV. Early diagnosis of Pancoast's tumor facilitated by bone scanning. Radiology. 1974;113(2):391-2.
  • 25. Shih WJ, DeLand FH, Domstad PA, Johnston EH. Extraosseous localization of 99mTc-MDP in ganglioneuroblastoma. Eur J Nucl Med. 1982;7(7):336-8.
  • 26. Romer W, Nömayr A, Uder M, Bautz W, Kuwert T. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med. 2006;47(7):1102-6.
  • 27. Utsunomiya D, Shiraishi S, Imuta M, et al. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology. 2006;238(1):264-71.
  • Address for correspondence:
    Majid Assadi
    Department of Nuclear Medicine, Persian Gulf Biomedical Sciences Institute, Boostan 19
    Alley, Imam Khomeini Street, Bushehr, Iran
    Tel. 0098-771-2580169
    Fax. 0098-771-2541828
    E-mail:
    E-mail:
  • Publication Dates

    • Publication in this collection
      22 Nov 2010
    • Date of issue
      July 2010

    History

    • Received
      14 Sept 2009
    • Reviewed
      10 June 2010
    • Accepted
      18 June 2010
    Associação Paulista de Medicina - APM APM / Publicações Científicas, Av. Brigadeiro Luís Antonio, 278 - 7º and., 01318-901 São Paulo SP - Brazil, Tel.: +55 11 3188-4310 / 3188-4311, Fax: +55 11 3188-4255 - São Paulo - SP - Brazil
    E-mail: revistas@apm.org.br